Essex Investment Management’s Champions Oncology CSBR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-77,200
| Closed | -$378K | – | 309 |
|
|
2024
Q1 | $378K | Hold |
77,200
| – | – | 0.07% | 183 |
|
|
2023
Q4 | $434K | Sell |
77,200
-28,135
| -27% | -$158K | 0.09% | 182 |
|
|
2023
Q3 | $654K | Sell |
105,335
-6,005
| -5% | -$37.3K | 0.11% | 225 |
|
|
2023
Q2 | $710K | Buy |
111,340
+3,685
| +3% | +$23.5K | 0.1% | 236 |
|
|
2023
Q1 | $433K | Hold |
107,655
| – | – | 0.06% | 258 |
|
|
2022
Q4 | $486K | Sell |
107,655
-56
| -0.1% | -$253 | 0.08% | 250 |
|
|
2022
Q3 | $808K | Sell |
107,711
-7,364
| -6% | -$55.2K | 0.13% | 209 |
|
|
2022
Q2 | $921K | Hold |
115,075
| – | – | 0.15% | 204 |
|
|
2022
Q1 | $936K | Buy |
115,075
+8,652
| +8% | +$70.4K | 0.12% | 228 |
|
|
2021
Q4 | $890K | Buy |
106,423
+16,916
| +19% | +$141K | 0.1% | 240 |
|
|
2021
Q3 | $914K | Sell |
89,507
-1,617
| -2% | -$16.5K | 0.11% | 232 |
|
|
2021
Q2 | $937K | Buy |
91,124
+892
| +1% | +$9.17K | 0.11% | 235 |
|
|
2021
Q1 | $1.02M | Hold |
90,232
| – | – | 0.12% | 230 |
|
|
2020
Q4 | $974K | Sell |
90,232
-53,956
| -37% | -$582K | 0.12% | 234 |
|
|
2020
Q3 | $1.33M | Sell |
144,188
-25,875
| -15% | -$239K | 0.19% | 175 |
|
|
2020
Q2 | $1.63M | Hold |
170,063
| – | – | 0.27% | 115 |
|
|
2020
Q1 | $1.26M | Sell |
170,063
-4,009
| -2% | -$29.7K | 0.25% | 129 |
|
|
2019
Q4 | $1.45M | Buy |
174,072
+35,840
| +26% | +$299K | 0.18% | 187 |
|
|
2019
Q3 | $781K | Hold |
138,232
| – | – | 0.11% | 245 |
|
|
2019
Q2 | $1.08M | Buy |
138,232
+58,260
| +73% | +$456K | 0.15% | 210 |
|
|
2019
Q1 | $783K | Buy |
79,972
+7,047
| +10% | +$69K | 0.12% | 227 |
|
|
2018
Q4 | $570K | Sell |
72,925
-5,514
| -7% | -$43.1K | 0.09% | 245 |
|
|
2018
Q3 | $1.37M | Sell |
78,439
-23,523
| -23% | -$411K | 0.16% | 189 |
|
|
2018
Q2 | $646K | Buy |
+101,962
| New | +$646K | 0.08% | 273 |
|